Trexquant Investment’s Soleno Therapeutics SLNO Stock Holding History

Trexquant Investment’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-221,928	Closed	-$7.43M	–	2204
2026 Q1	$7.43M	Buy	221,928 +89,016	+67%	+$3.49M	0.05%	490
2025 Q4	$6.15M	Buy	132,912 +122,576	+1,186%	+$6.72M	0.05%	499
2025 Q3	$699K	Sell	10,336 -22,491	-69%	-$1.67M	0.01%	1246
2025 Q2	$2.75M	Buy	32,827 +15,928	+94%	+$1.19M	0.03%	772
2025 Q1	$1.21M	Buy	+16,899	New	+$823K	0.01%	1031

Trexquant Investment's SLNO Position: Q2 2026 in Review

Trexquant Investment sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 221,928 shares — an estimated $7.43M sold.

Trexquant Investment first reported a position in SLNO in Q1 2025 and held it in 5 quarters. The position peaked at $7.43M in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Trexquant Investment reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Trexquant Investment sold 221,928 Soleno Therapeutics shares in Q2 2026, an estimated $7.43M.
Trexquant Investment first reported a position in Soleno Therapeutics in Q1 2025 and held it in 5 quarters.
Trexquant Investment's Soleno Therapeutics position peaked at $7.43M in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.